What Are the Functions of EDI Dilute and Concentrate Chambers in Industrial Water Purification?

In industrial water purification systems serving beverage, pharmaceutical, and electronics manufacturing, Electrodeionization (EDI) is commonly deployed after reverse osmosis (RO) to achieve ultra-low conductivity water. The core functionality of EDI relies on its dual-chamber design: dilute and concentrate chambers. These are not merely structural compartments—they are functionally interdependent units that enable continuous ion removal without acid or alkali regeneration.
The dilute chamber contains ion-exchange resins sandwiched between selective ion-exchange membranes. As feed water—typically RO permeate with conductivity below 50 μS/cm—flows through this chamber, dissolved ions (such as sodium, chloride, and silica) are attracted toward oppositely charged electrodes. The ion-exchange membranes allow only cations or anions to pass, directing them into the adjacent concentrate chamber while retaining purified water in the dilute stream. This selective transport mechanism is driven by a low-voltage DC current, which continuously regenerates the resin in place, eliminating the need for periodic chemical regeneration cycles.
The concentrate chamber, positioned between the dilute chamber and the electrode, collects the removed ions. It receives a portion of the feed water (or recycled brine) that flows parallel to the dilute stream. As ions migrate out of the dilute chamber, they enter this chamber and are carried away as a concentrated waste stream. This prevents ion buildup in the dilute chamber, which would otherwise reduce efficiency and risk membrane scaling. The concentrate stream is typically discharged or partially recycled, depending on system recovery targets and local wastewater constraints.
This design is not universally applicable. EDI systems require strict pre-treatment: feed water must be low in hardness (below 1 ppm as CaCO₃), silica (below 0.5 ppm), CO₂ (often reduced by degassing), and free chlorine (below 0.05 ppm). Exceeding these thresholds can cause resin fouling or membrane degradation, leading to performance loss or irreversible damage. Chuxin Mingwei’s EDI configurations are always integrated after a two-stage RO system, as specified in project-specific water quality reports, and never deployed as a standalone unit.
For clients evaluating EDI versus mixed-bed deionization, the key trade-off lies in operational continuity versus initial complexity. EDI offers uninterrupted operation and reduced chemical handling—critical for GMP environments in pharmaceutical water systems or high-volume bottled water production. However, it demands precise control of inlet water quality, consistent power supply, and regular monitoring of conductivity, flow rates, and voltage. Systems without adequate pre-treatment or real-time diagnostics will fail to sustain performance.
Chuxin Mingwei designs EDI modules as part of end-to-end water treatment systems, where dilute and concentrate chamber performance is validated against actual source water data and target resistivity requirements (e.g., ≥15 MΩ·cm for pharmaceutical-grade water). The system’s scalability and modular nature allow for capacity adjustments from 100 L/h to 10,000 L/h, but only when inlet conditions are confirmed through documented water analysis.
If your facility requires high-purity water without chemical regeneration, begin by reviewing your RO permeate quality. If conductivity exceeds 50 μS/cm, hardness is above 1 ppm, or silica levels are unknown, EDI may not be the optimal choice. Consult your water treatment engineer with your latest source water report before proceeding with EDI integration.
EDI systems require strict pre-treatment, including hardness control below 1 ppm as CaCO₃ and silica reduction below 0.5 ppm, as specified in SY-EDI-01(A) and JR-SOFT-01(A), where sodium ion exchange is applied to soften water prior to EDI. Without such pre-treatment, resin fouling or membrane scaling will occur, compromising continuous operation.